These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20972487)

  • 1. [Congenital vascular malformations: epidemiology, classification and therapeutic basis].
    Pereira Albino J
    Rev Port Cir Cardiotorac Vasc; 2010; 17(1):61-6. PubMed ID: 20972487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review.
    Blaise S; Charavin-Cocuzza M; Riom H; Brix M; Seinturier C; Diamand JM; Gachet G; Carpentier PH
    Eur J Vasc Endovasc Surg; 2011 Mar; 41(3):412-7. PubMed ID: 21111641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Percutaneous treatment of peripheral vascular malformations with a mixture of polidocanol and CO(2). Initial experience].
    Górriz Gómez E; Carreira JM
    Radiologia; 2008; 50(5):424-9. PubMed ID: 19055921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and Treatment of Venous Malformations. Consensus Document of the International Union of Phlebology (IUP): updated 2013.
    Lee BB; Baumgartner I; Berlien P; Bianchini G; Burrows P; Gloviczki P; Huang Y; Laredo J; Loose DA; Markovic J; Mattassi R; Parsi K; Rabe E; Rosenblatt M; Shortell C; Stillo F; Vaghi M; Villavicencio L; Zamboni P;
    Int Angiol; 2015 Apr; 34(2):97-149. PubMed ID: 24566499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new method for using radiopaque sclerosing foam to treat venous malformations.
    Li K; Liu YR; Chen AW; Liu SH
    Dermatol Surg; 2015 Jun; 41(6):726-30. PubMed ID: 25973562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and safety of polidocanol for the treatment of hemangiomas and vascular malformations: A meta-analysis.
    Gao Z; Zhang Y; Li W; Shi C
    Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29082587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Venous Malformations: The Data, Where We Are, and How It Is Done.
    Hage AN; Chick JFB; Srinivasa RN; Bundy JJ; Chauhan NR; Acord M; Gemmete JJ
    Tech Vasc Interv Radiol; 2018 Jun; 21(2):45-54. PubMed ID: 29784122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Extracranial vascular anomalies (hemangiomas and vascular malformations) in children and adolescents--diagnosis, clinic, and therapy].
    Eivazi B; Werner JA
    Laryngorhinootologie; 2014 Mar; 93 Suppl 1():S185-202. PubMed ID: 24710783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Volumetric assessment of results of treatment of vascular malformations of the head and neck regions treated with a minimally invasive surgical technique after embolization procedure.
    Konas E; Canter HI; Cil B; Peynircioglu B; Karabulut E; Tuncbilek G; Kayikcioglu A; Erk Y
    J Craniofac Surg; 2009 Mar; 20(2):402-5. PubMed ID: 19258907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular Anomalies (Part I): Classification and Diagnostics of Vascular Anomalies.
    Sadick M; Müller-Wille R; Wildgruber M; Wohlgemuth WA
    Rofo; 2018 Sep; 190(9):825-835. PubMed ID: 29874693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of Duplex-guided polidocanol foam sclerotherapy for venous malformations.
    Ali H; Saleh M; Mohammed W
    Int Angiol; 2017 Jun; 36(3):228-236. PubMed ID: 27362577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Classification of vascular tumours and vascular malformations. Contribution of the ISSVA 2014/2018 classification].
    Wassef M; Borsik M; Cerceau P; Faucon B; Laurian C; Le Clerc N; Lemarchand-Venencie F; Massoni C; Salvan D; Bisdorff-Bresson A
    Ann Pathol; 2021 Feb; 41(1):58-70. PubMed ID: 33309330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sclerotherapy in venous malformation.
    Rabe E; Pannier F
    Phlebology; 2013 Mar; 28 Suppl 1():188-91. PubMed ID: 23482557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of venous malformations with sclerosant in microfoam form.
    Cabrera J; Cabrera J; Garcia-Olmedo MA; Redondo P
    Arch Dermatol; 2003 Nov; 139(11):1409-16. PubMed ID: 14623700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular anomalies in pediatric patients: updated classification, imaging, and therapy.
    Kollipara R; Odhav A; Rentas KE; Rivard DC; Lowe LH; Dinneen L
    Radiol Clin North Am; 2013 Jul; 51(4):659-72. PubMed ID: 23830791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sclerotherapy of face and oral cavity low flow vascular malformations: our experience.
    Górriz-Gómez E; Vicente-Barrero M; Loras-Caballero ML; Bocanegra-Pérez S; Castellano-Navarro JM; Pérez-Plasencia D; Ramos-Macías A
    Br J Oral Maxillofac Surg; 2014 Jan; 52(1):43-7. PubMed ID: 23660343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foam sclerotherapy using polidocanol (aethoxysklerol) for preoperative portal vein embolization in 16 patients.
    Chung SH; Lee MS; Kim KS; Kim SI; Won JY; Lee DY; Lee KH
    Cardiovasc Intervent Radiol; 2011 Dec; 34(6):1236-43. PubMed ID: 21290126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brief Description of ISSVA Classification for Radiologists.
    Monroe EJ
    Tech Vasc Interv Radiol; 2019 Dec; 22(4):100628. PubMed ID: 31864528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experimental study of intraarterial injection of polidocanol as an embolic agent].
    Shirai H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1999 Dec; 59(14):853-9. PubMed ID: 10655710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ISSVA Classification of Vascular Anomalies and Molecular Biology.
    Kunimoto K; Yamamoto Y; Jinnin M
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.